Insurance Exclusion of Compounded Drugs

By Insurance Review Editorial ·

Insurance Exclusion of Compounded Drugs

With growing interest in GLP-1 therapies, understanding insurance exclusion of compounded drugs has become a priority for patients and providers alike. Here we present a balanced, evidence-based overview.


Coverage Analysis

Our analysis of this plan indicates important considerations for anyone needing weight loss medication coverage:


What You Will Pay

Estimating what you will pay requires looking at various elements:

| Factor | Estimate | |---|---| | Drug copay | $50-200 | | Before deductible | Depends on plan | | Annual max OOP | $3,000-8,000 | | Copay assistance | Most patients |

After meeting your deductible, coverage typically move to a percentage split at a reduced rate up to you reach your annual OOP max.


Steps to Approval

  1. Verify coverage — Search your plan’s formulary by contacting member services
  2. Get doctor documentation — Your physician needs to document the clinical rationale with diagnoses and failed prior treatments
  3. Submit prior auth — The prescriber submits the prior authorization to the pharmacy benefit manager
  4. File an appeal — Upon denial, there is the right to contest the decision — approval on appeal are significant

Assessment

After analyzing formulary coverage, approval difficulty, and patient cost, we score this plan for Ozempic and Wegovy users:


Frequently Asked Questions

Does this plan cover Ozempic?

Coverage varies by your particular product you have and your specific diagnosis. Diabetes prescriptions are more likely to be covered than weight loss indications.

What if my prior authorization is denied?

Contest the denial right away. Provide supporting medical records from your doctor. Over half succeed upon review with adequate documentation.